These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10842897)

  • 1. [The role of angiotensin II inhibitors in arterial hypertension: clinical trials and guidelines].
    Mancia G; Grassi G
    Ann Ital Med Int; 2000; 15(1):92-5. PubMed ID: 10842897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
    Weber MA
    Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists.
    Volpe M
    J Hum Hypertens; 2005 Feb; 19(2):93-102. PubMed ID: 15457205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
    Stewart JR; Yeun JY
    Minerva Med; 2003 Aug; 94(4):215-27. PubMed ID: 14605587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
    de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of antihypertensive drug in the diabetic patient.
    Ong HT; Cheah JS
    MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II antagonists in the treatment of hypertension-effective and efficient?
    Müller-Nordhorn J; Willich SN
    Herz; 2003 Dec; 28(8):733-7. PubMed ID: 14689108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].
    Stern N; Grossman E; ; ; ;
    Harefuah; 2003 Apr; 142(4):309-11, 315. PubMed ID: 12754885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeking the ideal anti-hypertensive agent: a practical review of the hypertension drug trials.
    Ong HT; Cheah JS
    N Z Med J; 2004 Feb; 117(1189):U773. PubMed ID: 15014562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable].
    Pischon T; Sharma AM
    MMW Fortschr Med; 2001 Nov; 143(48):34-8. PubMed ID: 11770373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of angiotensin converting enzyme inhibition and angiotensin II receptor antagonists in hypertension.
    Conlin PR
    J Med Liban; 2000; 48(6):382-6. PubMed ID: 11503531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.